This is not the EXCAT Science board. Colon cancer and cervical cancer are VERY DIFFERENT. News flash: cervical cancer affects women only. And the tests use very different technology.
How does GTHP need to "shuffle the crew?" I thought they had a genius CEO -- who needs to get shuffled?
GTHP can't keep the O/S capped at 16M or any other number because selling convertible debt is their ONLY way to get funding.
GTHP/Apple can team up... how? APPLE needs to buy zombie pinksheet biotech companies to save their falling stock?